- Home
- CVSA
as of 09-18-2026 3:35pm EST
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 4.5B | IPO Year: | 1995 |
| Target Price: | $150.00 | AVG Volume (30 days): | 291.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | 7.04 | EPS Growth: | 13.92 |
| 52 Week Low/High: | $96.08 - $142.13 | Next Earning Date: | 05-07-2026 |
| Revenue: | $1,954,085,000 | Revenue Growth: | 9.27% |
| Revenue Growth (this year): | 9.66% | Revenue Growth (next year): | 6.58% |
| P/E Ratio: | 17.96 | Index: | N/A |
| Free Cash Flow: | 392.7M | FCF Growth: | +57.39% |
Stock Insider Trading Activity of Covista Inc. Common Shares (CVSA)
VP, Chief Accounting Officer
Avg Cost/Share
$137.18
Shares
1,802
Total Value
$247,198.36
Owned After
5,083
SEC Form 4
Chairman & CEO
Avg Cost/Share
$130.35
Shares
3,545
Total Value
$462,073.03
Owned After
415,197
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$135.15
Shares
2,186
Total Value
$295,437.90
Owned After
48,306
SEC Form 4
SVP, GC, Corp. Sec & ISS
Avg Cost/Share
$135.81
Shares
4,526
Total Value
$614,676.06
Owned After
28,544
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Gangadharan Manjunath | CVSA | VP, Chief Accounting Officer | Aug 27, 2026 | Sell | $137.18 | 1,802 | $247,198.36 | 5,083 | |
| Beard, Stephen W. | CVSA | Chairman & CEO | Aug 11, 2026 | Sell | $130.35 | 3,545 | $462,073.03 | 415,197 | |
| Phelan Robert J. | CVSA | Chief Financial Officer | Aug 7, 2026 | Sell | $135.15 | 2,186 | $295,437.90 | 48,306 | |
| BECK DOUGLAS G. | CVSA | SVP, GC, Corp. Sec & ISS | Aug 7, 2026 | Sell | $135.81 | 4,526 | $614,676.06 | 28,544 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K Aug 6, 2026
Q2 2026 Earnings
8-KAug 6, 2026
2026 Q1 Q1 2026 Earnings
8-K May 7, 2026
Q1 2026 Earnings
8-KMay 7, 2026
2025 Q4 Q4 2025 Earnings
8-K Jan 28, 2026
Q4 2025 Earnings
8-KJan 28, 2026
Compare CVSA vs Leading Stocks
See how CVSA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CVSA Covista Inc. Common Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.